Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T22:13:43.981Z.
Calculation as of: 2026-10-06T22:13:43.981Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 667dd3b64d3a271f66e92979ae52668ccbc7e2b5b2cdee7c8377401ac3ef4785
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
Tectonic Therapeutic, Inc.
Market Cap
$422.86M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$422.72M
EV/EBITDA Ratio
22.89x
TTM Avg
25.27x
3Y Avg
25.27x
5Y Avg
25.27x
Market Cap
$424.10M
EV/EBITDA Ratio
N/A
TTM Avg
74.72x
3Y Avg
37.71x
5Y Avg
26.88x
Market Cap
$419.87M
EV/EBITDA Ratio
N/A
TTM Avg
16.39x
3Y Avg
16.39x
5Y Avg
16.39x
Market Cap
$426.51M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$416.27M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tectonic Therapeutic, Inc. (TECX) | $422.86M | N/A | N/A | N/A | N/A |
| Tilray Brands, Inc. (TLRY)vs › | $422.72M | 22.89x | 25.27x | 25.27x | 25.27x |
| NeoGenomics, Inc. (NEO)vs › | $424.10M | N/A | 74.72x | 37.71x | 26.88x |
| Prothena Corporation plc (PRTA)vs › | $419.87M | N/A | 16.39x | 16.39x | 16.39x |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $426.51M | N/A | N/A | N/A | N/A |
| Editas Medicine, Inc. (EDIT)vs › | $418.95M | N/A | N/A | N/A | N/A |
| Senseonics Holdings, Inc. (SENS)vs › | $416.27M | N/A | N/A | N/A | N/A |
| Rezolute, Inc. (RZLT)vs › | $415.98M | N/A | N/A | N/A | N/A |
| NeuroPace, Inc. (NPCE)vs › | $431.97M | N/A | N/A | N/A | N/A |
| MapLight Therapeutics, Inc. (MPLT)vs › | $411.21M | N/A | N/A | N/A | N/A |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
